PIK3CA mutations in glioblastoma multiforme

被引:85
|
作者
Hartmann, C [1 ]
Bartels, G [1 ]
Gehlhaar, C [1 ]
Holtkamp, N [1 ]
von Deimling, A [1 ]
机构
[1] Univ Med Berlin, Charite, Dept Neuropathol, D-13353 Berlin, Germany
关键词
glioblastoma multiforme; PIK3CA; PTEN; chromosome; 10; TP53;
D O I
10.1007/s00401-005-1000-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Glioblastoma multiforme WHO grade IV is the most common and malignant variant of astrocytic tumors. Loss of heterozygosity of chromosome 10 and mutations in the tumor suppressor gene PTEN on 10q are molecular hallmarks of glioblastomas. Recently, mutations were identified in PIK3CA, encoding a protein that antagonizes the function of PTEN protein in the PI3K/Akt pathway. To address the question whether an exclusive mutation pattern can be observed in PIK3CA and PTEN, we determined the frequency of mutations in both genes. All coding exons were examined by single strand confirmation polymorphism and direct sequencing. Additionally, we analyzed chromosome 10 for loss of heterozygosity and evaluated the mutational status of TP53. In 70 glioblastomas, 5 (7%) PIK3CA mutations and 10 (14%) PTEN mutations were found. All mutations in PIK3CA located to exons 1, 9 and 20, thereby supporting the concept of mutational hot spot regions. In all but one glioblastoma, mutations were seen either in PIK3CA or in PTEN. In conclusion, the frequency of PIK3CA mutations in glioblastomas appears to be much lower than initially reported.
引用
收藏
页码:639 / 642
页数:4
相关论文
共 50 条
  • [31] PIK3CA mutations matter for cancer in dogs
    Kim, Jong Hyuk
    RESEARCH IN VETERINARY SCIENCE, 2020, 133 : 39 - 41
  • [32] PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma
    Shota Tanaka
    Tracy T. Batchelor
    A. John Iafrate
    Dora Dias-Santagata
    Darrell R. Borger
    Leif W. Ellisen
    Daniel Yang
    David N. Louis
    Daniel P. Cahill
    Andrew S. Chi
    Acta Neuropathologica Communications, 7
  • [33] PIK3CA MUTATIONS PREDICT FOR RESPONSE TO ASPIRIN THERAPY
    不详
    CANCER DISCOVERY, 2012, 2 (12) : 1073 - 1073
  • [34] Detection of PIK3CA/AKT mutations in human meningiomas
    Saetta, A.
    Tomara, G.
    Chatziandreou, I.
    Tsioli, P.
    El-Habr, E.
    Sakalidou, I.
    Vretakos, G.
    Boviatsis, E.
    Korkolopoulou, P.
    Patsouris, E.
    VIRCHOWS ARCHIV, 2012, 461 : S170 - S170
  • [35] PIK3CA mutations in pancreatic ductal adenocarcinoma (PDAC)
    Pitiyarachchi, O.
    Sim, H-W.
    ANNALS OF ONCOLOGY, 2024, 35 : S1499 - S1499
  • [36] PIK3CA Mutations in In situ and Invasive Breast Carcinomas
    Miron, Alexander
    Varadi, Maria
    Carrasco, Daniel
    Li, Hailun
    Luongo, Lauren
    Kim, Hee Jung
    Park, So Yeon
    Cho, Eun Yoon
    Lewis, Gretchen
    Kehoe, Sarah
    Iglehart, J. Dirk
    Dillon, Deborah
    Allred, D. Craig
    Macconaill, Laura
    Gelman, Rebecca
    Polyak, Kornelia
    CANCER RESEARCH, 2010, 70 (14) : 5674 - 5678
  • [37] Mutations of the PIK3CA gene in hereditary colorectal cancers
    Miyaki, Michiko
    Iijima, Takeru
    Yamaguchi, Tatsuro
    Takahashi, Keiichi
    Matsmnoto, Hiroshi
    Yasutome, Michiya
    Funata, Nobuaki
    Mori, Takeo
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (07) : 1627 - 1630
  • [38] Frequency of PIK3CA Mutations and Therapeutic Outcomes in NSCLC
    Martos, G.
    Bebb, G.
    Pabani, A.
    Gibson, A.
    Dean, M.
    Petersen, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1161 - S1162
  • [39] The prevalence of PIK3CA mutations in gastric and colon cancer
    Velho, S
    Oliveira, C
    Ferreira, A
    Ferreira, AC
    Suriano, G
    Schwartz, S
    Duval, A
    Carneiro, F
    Machado, JC
    Hamelin, R
    Seruca, R
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (11) : 1649 - 1654
  • [40] PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma
    Tanaka, Shota
    Batchelor, Tracy T.
    Iafrate, A. John
    Dias-Santagata, Dora
    Borger, Darrell R.
    Ellisen, Leif W.
    Yang, Daniel
    Louis, David N.
    Cahill, Daniel P.
    Chi, Andrew S.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 (1) : 66